rs40200
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_031900.4(AGXT2):c.88+2165T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.844 in 152,034 control chromosomes in the GnomAD database, including 54,671 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.84 ( 54671 hom., cov: 31)
Consequence
AGXT2
NM_031900.4 intron
NM_031900.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.609
Publications
16 publications found
Genes affected
AGXT2 (HGNC:14412): (alanine--glyoxylate aminotransferase 2) The protein encoded by this gene is a class III pyridoxal-phosphate-dependent mitochondrial aminotransferase. It catalyzes the conversion of glyoxylate to glycine using L-alanine as the amino donor. It is an important regulator of methylarginines and is involved in the control of blood pressure in kidney. Polymorphisms in this gene affect methylarginine and beta-aminoisobutyrate metabolism, and are associated with carotid atherosclerosis. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2015]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.97).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.894 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| AGXT2 | ENST00000231420.11 | c.88+2165T>C | intron_variant | Intron 1 of 13 | 1 | NM_031900.4 | ENSP00000231420.6 | |||
| AGXT2 | ENST00000510428.1 | c.88+2165T>C | intron_variant | Intron 1 of 12 | 1 | ENSP00000422799.1 | ||||
| AGXT2 | ENST00000618015.4 | c.88+2165T>C | intron_variant | Intron 1 of 11 | 5 | ENSP00000479154.1 | ||||
| AGXT2 | ENST00000505542.1 | n.86+2165T>C | intron_variant | Intron 1 of 4 | 2 |
Frequencies
GnomAD3 genomes AF: 0.844 AC: 128166AN: 151918Hom.: 54643 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
128166
AN:
151918
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.844 AC: 128241AN: 152034Hom.: 54671 Cov.: 31 AF XY: 0.841 AC XY: 62460AN XY: 74310 show subpopulations
GnomAD4 genome
AF:
AC:
128241
AN:
152034
Hom.:
Cov.:
31
AF XY:
AC XY:
62460
AN XY:
74310
show subpopulations
African (AFR)
AF:
AC:
33020
AN:
41428
American (AMR)
AF:
AC:
11697
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
AC:
3034
AN:
3472
East Asian (EAS)
AF:
AC:
2830
AN:
5158
South Asian (SAS)
AF:
AC:
4007
AN:
4814
European-Finnish (FIN)
AF:
AC:
9512
AN:
10566
Middle Eastern (MID)
AF:
AC:
268
AN:
294
European-Non Finnish (NFE)
AF:
AC:
61208
AN:
68000
Other (OTH)
AF:
AC:
1827
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
936
1872
2807
3743
4679
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
882
1764
2646
3528
4410
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2454
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.